154 related articles for article (PubMed ID: 37225627)
21. Clonal B-cell proliferations developing in the background of primary cutaneous CD4
Ates Ozdemir D; Akdoğan N; Okay M; Uner A; Saglam A
J Cutan Pathol; 2022 Nov; 49(11):971-977. PubMed ID: 35871674
[TBL] [Abstract][Full Text] [Related]
22. Primary Cutaneous CD4
Maurelli M; Colato C; Gisondi P; Girolomoni G
J Cutan Med Surg; 2017; 21(6):502-506. PubMed ID: 28605998
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound Appearance of Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder.
Rodríguez-Lomba E; Molina-López I; Pulido-Pérez A; Ciudad-Blanco C
Actas Dermosifiliogr; 2017 Oct; 108(8):792-794. PubMed ID: 28388988
[No Abstract] [Full Text] [Related]
24. Long-term follow-up and management of small and medium-sized CD4
Virmani P; Jawed S; Myskowski PL; Horwitz S; Skripnik Lucas A; Moskowitz A; Pulitzer M; Zain J; Rosen ST; Querfeld C
Int J Dermatol; 2016 Nov; 55(11):1248-1254. PubMed ID: 27369070
[TBL] [Abstract][Full Text] [Related]
25. Indolent primary cutaneous CD8 positive T-cell lymphoid proliferations.
Hakemi Y; Pyne J; Muljono A; Myint E
Pathology; 2018 Aug; 50(5):575-578. PubMed ID: 29908842
[No Abstract] [Full Text] [Related]
26. Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria.
Bakr F; Wain EM; Wong S; Palmer R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e190-e196. PubMed ID: 33989212
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior.
Grogg KL; Jung S; Erickson LA; McClure RF; Dogan A
Mod Pathol; 2008 Jun; 21(6):708-15. PubMed ID: 18311111
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation.
Kim EJ; Aria AB; Wilmas K; Lewis DJ; Torres-Cabala CA; Nunez C; Dabaja BS; Duvic M
Pediatr Dermatol; 2019 Jan; 36(1):e23-e26. PubMed ID: 30548331
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma.
Alberti-Violetti S; Torres-Cabala CA; Talpur R; Corti L; Fanoni D; Venegoni L; Berti E; Duvic M
J Cutan Pathol; 2016 Dec; 43(12):1121-1130. PubMed ID: 27550169
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4
Oschlies I; Kock K; Wüseke T; Richter J; Koch K; Wehkamp U; Klapper W
Histopathology; 2023 Feb; 82(3):485-494. PubMed ID: 36341542
[TBL] [Abstract][Full Text] [Related]
31. A case of primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma.
Hou S; Liu X; Liu J; Zhang Z; Wang B; Han C
Eur J Dermatol; 2016 Dec; 26(6):629-630. PubMed ID: 27629423
[No Abstract] [Full Text] [Related]
32. Targeting the cutaneous lymphocyte antigen (CLA) in inflammatory and neoplastic skin conditions.
Sernicola A; Russo I; Silic-Benussi M; Ciminale V; Alaibac M
Expert Opin Biol Ther; 2020 Mar; 20(3):275-282. PubMed ID: 31951753
[No Abstract] [Full Text] [Related]
33. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
Kikuchi A; Nishikawa T
Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
[TBL] [Abstract][Full Text] [Related]
34. Signet ring cell primary cutaneous CD30+ lymphoproliferative disorder presenting as a monomorphic T-cell posttransplant lymphoproliferative disease.
Papalas JA; Kulbacki EL; Park HK; Howell ER
Am J Dermatopathol; 2012 Oct; 34(7):e94-6. PubMed ID: 22534639
[TBL] [Abstract][Full Text] [Related]
35. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category.
Williams VL; Torres-Cabala CA; Duvic M
Am J Clin Dermatol; 2011 Dec; 12(6):389-401. PubMed ID: 21863906
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous CD4+ small/medium T-cell lymphoma with aggressive clinical course.
Yasuda M; Igarashi N; Nagai Y; Tamura A; Ishikawa O
Australas J Dermatol; 2014 Nov; 55(4):304-6. PubMed ID: 25399792
[No Abstract] [Full Text] [Related]
37. Cutaneous Small/Medium CD4+ Pleomorphic T-Cell Lymphoma-Like Nodule in a Patient With Erythema Chronicum Migrans.
Celebi Cherukuri N; Roth CG; Aggarwal N; Ho J; Gehris R; Akilov OE
Am J Dermatopathol; 2016 Jun; 38(6):448-52. PubMed ID: 27097344
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
39. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.
Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR
J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous CD4
Besch-Stokes JG; Costello CM; Severson KJ; Bhullar P; Montoya J; Butterfield RJ; DiCaudo DJ; Comfere N; Sluzevich J; Rule W; Craig FE; Rosenthal A; Pittelkow MR; Mangold AR
J Am Acad Dermatol; 2022 May; 86(5):1167-1169. PubMed ID: 33915243
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
